Library — CHDR

Search

Filter

Repeated intravenous esketamine treatment in patients with ECT-resistant major depressive disorder

A.Safai Pour, S.J.M.van der Aalst, I.J.Brouwer, E.J.Giltay, G.E.Jacobs, N.J.A.van der Wee, A.M.van Hemert, M.S.van Noorden

Journal of Affective Disorders Reports, 2022 Aug

View publication
Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equations.

Liu F, Aulin LBS, Guo T, Krekels EHJ, Moerland M, van der Graaf PH, van Hasselt JGC

British journal of clinical pharmacology, 2022 Aug

View publication
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease.

Prins S, de Kam ML, Teunissen CE, Groeneveld GJ

Alzheimer's research & therapy, 2022 Aug; 14(1):106

View publication
Highlighting the Undetectable - Fluorescence Molecular Imaging in Gastrointestinal Endoscopy.

Stibbe JA, Hoogland P, Achterberg FB, Holman DR, Sojwal RS, Burggraaf J, Vahrmeijer AL, Nagengast WB, Rogalla S

Molecular imaging and biology, 2022 Jun

View publication
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.

Harrison SA, Manghi FP, Smith WB, Alpenidze D, Aizenberg D, Klarenbeek N, Chen CY, Zuckerman E, Ravussin E, Charatcharoenwitthaya P, Cheng PN, Katchman H, Klein S, Ben-Ari Z, Mendonza AE, Zhang Y, Martic M, Ma S, Kao S, Tanner S, Pachori A, Badman MK, He Y, Ukomadu C, Sicard E

Nature medicine, 2022 Jun

View publication
Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a (Al)Al microtracer approach: a follow-up study in humans.

de Ligt R, Westerhout J, Grossouw D, Buters TP, Rissmann R, Burggraaf J, Windhorst AD, Tozer S, Pappa G, Wall B, Bury D, Mason DR, Vaes WHJ

Toxicology research, 2022 Jun; 11(3):511-519

View publication
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.

Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C

Clinical and translational science, 2022 Jun

View publication
A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine

Hui Jing Yu, Eva Thijssen, Emilie van Brummelen, Johan L. van der Plas, Igor Radanovic, Matthijs Moerland, Eric Hsieh, Geert Jan Groeneveld, Jean-Cosme Dodart

2022 Apr

View publication
Clinical Pharmacology of Radiotheranostics in Oncology.

Te Beek ET, Burggraaf J, Teunissen JJM, Vriens D

Clinical pharmacology and therapeutics, 2022 Apr

View publication

«
1
2
3
4
5
6
7
8
...
87
88
»